A review of clinical endpoints and use of quality of life outcomes in phase III metastatic breast cancer clinical trials.
Raman Tatla
No relevant relationships to disclose
Denis Landaverde
No relevant relationships to disclose
Charles Victor
No relevant relationships to disclose
David Miles
No relevant relationships to disclose
Sunil Verma
No relevant relationships to disclose